Hepatitis B and C infections, and co-infections screening among patients attending a tertiary hospital in Addis Ababa, Ethiopia: a retrospective database study

Hepatitis B and C virus infection is a continuous public health problem in Ethiopia, with the prevalence of the disease significantly varying across administrative regions. Determining seroprevalence among people who are unaware of their infection status is essential for hepatitis diagnosis and treatment. We aimed to determine the seroprevalence of two hepatitis viruses among patients attending different service areas in a tertiary hospital in Ethiopia. We conducted an institution-based retrospective study using serology laboratory data from January 2021 to December 2023 at Yekatit 12 Hospital Medical College in Addis Ababa. We retrieved hepatitis B virus and hepatitis C virus data from electronic databases. We ran a binary logistic regression analysis to assess the relationship between dependent and independent variables. Statistical significance was determined for variables having a P-value (P < 0.05) and 95% confidence intervals. A total of 3332 and 9890 patients’ blood samples were screened for hepatitis B and C virus, respectively. The prevalence of hepatitis B was 5.4% (179/3332), and hepatitis C virus was 1.8% (175/9890). The overall prevalence of co-infection was 0.2% (7/3322). Hepatitis B virus prevalence fluctuated, while hepatitis C virus prevalence steadily increased from 2021 to 2023. The positivity rate of the hepatitis B virus is 5.4% (89/1643) and hepatitis C virus 1.86% (93/5414) among female patients. Age was significantly associated with hepatitis B and C virus infection. The two viruses have been found at a significantly higher prevalence rate among admitted and emergency department patients. An intermediate seroprevalence of HBV and hepatitis C virus infection was detected among participants in our study area. Screening for hepatitis B and C can be beneficial in identifying people with viral hepatitis and offering a chance to engage them in specialized care.

Authors

Institutions

Publication Details

Journal
BMC Gastroenterology
Published
2025-12-12
DOI
https://doi.org/10.1186/s12876-025-04541-3
Primary Topic
Hepatitis C virus research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hepatitis B and C infections, and co-infections screening among patients attending a tertiary hospital in Addis Ababa, Ethiopia: a retrospective database study

Amdemeskel Mersha, Balew Arega, Ermias Algawork Kibru, Kibrom Hailemariam Mesfin et al.
BMC Gastroenterology
Hepatitis C virus research
article

Hepatitis B and C infections, and co-infections screening among patients attending a tertiary hospital in Addis Ababa, Ethiopia: a retrospective database study

Amdemeskel Mersha, Balew Arega, Ermias Algawork Kibru, Kibrom Hailemariam Mesfin, Alemayehu Worku, Ermiyas Tefera, Daniel Achame, Dawit Tolossa, Nebyu Tafasse
article en

Abstract

Hepatitis B and C virus infection is a continuous public health problem in Ethiopia, with the prevalence of the disease significantly varying across administrative regions. Determining seroprevalence among people who are unaware of their infection status is essential for hepatitis diagnosis and treatment. We aimed to determine the seroprevalence of two hepatitis viruses among patients attending different service areas in a tertiary hospital in Ethiopia. We conducted an institution-based retrospective study using serology laboratory data from January 2021 to December 2023 at Yekatit 12 Hospital Medical College in Addis Ababa. We retrieved hepatitis B virus and hepatitis C virus data from electronic databases. We ran a binary logistic regression analysis to assess the relationship between dependent and independent variables. Statistical significance was determined for variables having a P-value (P < 0.05) and 95% confidence intervals. A total of 3332 and 9890 patients’ blood samples were screened for hepatitis B and C virus, respectively. The prevalence of hepatitis B was 5.4% (179/3332), and hepatitis C virus was 1.8% (175/9890). The overall prevalence of co-infection was 0.2% (7/3322). Hepatitis B virus prevalence fluctuated, while hepatitis C virus prevalence steadily increased from 2021 to 2023. The positivity rate of the hepatitis B virus is 5.4% (89/1643) and hepatitis C virus 1.86% (93/5414) among female patients. Age was significantly associated with hepatitis B and C virus infection. The two viruses have been found at a significantly higher prevalence rate among admitted and emergency department patients. An intermediate seroprevalence of HBV and hepatitis C virus infection was detected among participants in our study area. Screening for hepatitis B and C can be beneficial in identifying people with viral hepatitis and offering a chance to engage them in specialized care.

BMC GastroenterologyVol. 26(1)
St. Paul's Hospital Millennium Medical College (ET), Addis Ababa University (ET), Mekelle University (ET)
Openalex Percentile: Top 47%
Hepatitis C virus research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.